Non-invasive molecular assessment of human embryo development and implantation potential.


Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
01 Jun 2020
Historique:
received: 17 02 2020
revised: 06 03 2020
accepted: 07 03 2020
pubmed: 7 4 2020
medline: 12 1 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

In vitro fertilization (IVF) is the most common assisted reproductive technology used to treat infertility. Embryo selection for transfer in IVF cycles relies on the morphological evaluation by embryologists, either by conventional microscopic assessment or more recently by time-lapse imaging systems. Despite the introduction of time-lapse imaging improvements in IVF success rates have failed to materialize, therefore alternative approaches are needed. Recent studies have shown that embryos resulting in successful pregnancy differ in their secretome and metabolism compared to embryos that fail to implant, suggesting that molecular analysis of embryo culture medium could assist in non-invasive single embryo selection. However, this approach has yet to be adopted clinically due to the lack of appropriate highly sensitive screening technologies needed to assess volume-limited samples. Here we report the detection of hCGβ, IL-8 and TNFα from conditioned culture media of single human embryos using electrochemical impedance spectroscopy. The impedimetric immunosensors revealed that morphologically non-viable embryos produce higher levels of IL-8 and TNFα, associated with abnormal cell division and cell death, respectively. More importantly, hCGβ detection was able to discriminate apparently morphologically identical viable embryos. This work brings an objective dimension to embryo selection, which could overcome the major limitations of morphology-based embryo selection for implantation. Future work should include the validation of these biomarkers in a large patient cohort.

Identifiants

pubmed: 32250927
pii: S0956-5663(20)30142-1
doi: 10.1016/j.bios.2020.112144
pii:
doi:

Substances chimiques

Chorionic Gonadotropin, beta Subunit, Human 0
Culture Media, Conditioned 0
Interleukin-8 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112144

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Catarina M Abreu (CM)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal; Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Centre for NanoHealth, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.

Victoria Thomas (V)

Wales Fertility Institute Neath, Neath Port Talbot Hospital, Swansea Bay University Health Board, Port Talbot, SA12 7BX, UK.

Paul Knaggs (P)

Wales Fertility Institute Neath, Neath Port Talbot Hospital, Swansea Bay University Health Board, Port Talbot, SA12 7BX, UK.

Adnan Bunkheila (A)

Singleton Hospital, Swansea Bay University Health Board, Sketty Lane, Swansea, SA2 8QA, UK.

Andrea Cruz (A)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal.

Sofia R Teixeira (SR)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal; Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Centre for NanoHealth, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.

Pedro Alpuim (P)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal.

Lewis W Francis (LW)

Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Centre for NanoHealth, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.

Amr Gebril (A)

Wales Fertility Institute Neath, Neath Port Talbot Hospital, Swansea Bay University Health Board, Port Talbot, SA12 7BX, UK.

Ahmed Ibrahim (A)

Wales Fertility Institute Neath, Neath Port Talbot Hospital, Swansea Bay University Health Board, Port Talbot, SA12 7BX, UK.

Lavinia Margarit (L)

Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Princess of Wales Hospital, Cwm Taf Morgannwg University Health Board, Coity Road, Bridgend, CF31 1RQ, UK.

Deyarina Gonzalez (D)

Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Centre for NanoHealth, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.

Paulo P Freitas (PP)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal.

R Steven Conlan (RS)

Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK; Centre for NanoHealth, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.

Inês Mendes Pinto (I)

International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330, Braga, Portugal. Electronic address: ines.m.pinto@inl.int.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH